Cargando…
P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI-CENTER PROSPECTIVE COHORT STUDY
Autores principales: | Tesi, Bianca, Eriksson, Anna, Baskin, Berivan, Lazarevic, Vladimir, Deneberg, Stefan, Höglund, Martin, Fogelstrand, Linda, Ungerstedt, Johanna, Pandzic, Tatjana, Tobiasson, Magnus, Gravdahl Garelius, Hege, Kuchinskaya, Ekaterina, Persson, Fredrik, Ågerstam, Helena, Uggla, Bertil, Hallböök, Helene, Fioretos, Thoas, Thuresson, Ann-Charlotte, Lehmann, Sören, Ladenvall, Claes, Barbany, Gisela, Vennström, Lovisa, Ejerblad, Elisabeth, Cavelier, Lucia, Cammenga, Jörg, Jädersten, Martin, Hellström Lindberg, Eva, Baliakas, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429588/ http://dx.doi.org/10.1097/01.HS9.0000968932.79062.9d |
Ejemplares similares
-
P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY.
por: Juliusson, Gunnar, et al.
Publicado: (2023) -
Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study
por: Lindholm, C., et al.
Publicado: (2022) -
Omalizumab alleviates pruritus in myeloproliferative neoplasms
por: Landtblom, Anna Ravn, et al.
Publicado: (2023) -
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
por: Berglund, Eva, et al.
Publicado: (2022) -
Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
por: Pandzic, Tatjana, et al.
Publicado: (2022)